The lateral organization of cellular membranes is formed by the clustering of specific lipids, such as cholesterol and sphingolipids, into highly condensed domains (termed lipid rafts). Hence such domains are distinct from the remaining membrane by their lipid structure (liquid-ordered vs. -disordered domains). Here, we directly visualize membrane lipid structure of living cells by using two-photon microscopy. In macrophages, liquid-ordered domains are particularly enriched on membrane protrusions (filopodia), adhesion points and cell-cell contacts and cover 10 -15% of the cell surface at 37°C. By deconvoluting the images, we demonstrate the existence of phase separation in vivo. We compare the properties of microscopically visible domains (<1 m 2 ), with those of isolated detergent-resistant membranes and provide evidence that membrane coverage by lipid rafts and their fluidity are principally governed by cholesterol content, thereby providing strong support for the lipid raft hypothesis. membrane domains ͉ macrophages T he lipid raft hypothesis proposes that the lateral organization of cellular membranes is based on the presence of distinct, cholesterol-rich, rigid domains (rafts) (1), which are involved in signal transduction (2), protein sorting, and membrane transport (3, 4). Our understanding of lipid structure and the formation of specific lipid domains within membranes, however, is almost exclusively based on model membrane systems (5). Although phase separation of domains of liquid-ordered structure is predicted to exist in cellular membranes (6, 7), direct demonstration using methodologies such as fluorescence quenching has been difficult to apply to living cells (8). The evidence for the existence of lipid rafts in living cells is largely based on measurements of the clustering (9, 10) or diffusion (11, 12) of lipid raft proteins, which are secondary to the lipid organization.In the present study, we labeled living cells with the fluorescent probe 6-acyl-2-dimethylaminonapthalene (Laurdan), which has been previously used to characterize domain formation and phase separation in model membranes using phospholipid mixtures (13-15) or lipid extracted from cellular membranes (16)(17)(18). Laurdan is an environmentally sensitive fluorescence probe that exhibits a 50-nm red shift as membranes undergo phase transition from gel to fluid, due to altered water penetration into the lipid bilayer (19). Its dipole is aligned parallel to the hydrophobic lipid chains in membranes and is located in both bilayers (20). The probe's fluorescence in water is negligible, and it is not influenced spectroscopically by surface modifications such as lipoprotein binding (20,21). The environmentally induced red shift allows the translation of intensity measurements at different wavelengths into lipid packing orders within the membranes of intact and living cells (20,22,23). Generalized polarization (GP), with a correcting factor G for the experimental setup, is defined analogously to fluorescence polarization by measuring the in...

No abstract

No abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive scarring disease of the lung with few effective therapeutic options. Structural remodelling of the extracellular matrix [i.e. collagen cross-linking mediated by the lysyl oxidase (LO) family of enzymes (LOX, LOXL1-4)] might contribute to disease pathogenesis and represent a therapeutic target. This study aimed to further our understanding of the mechanisms by which LO inhibitors might improve lung fibrosis. Lung tissues from IPF and non-IPF subjects were examined for collagen structure (second harmonic generation imaging) and LO gene (microarray analysis) and protein (immunohistochemistry and western blotting) levels. Functional effects (collagen structure and tissue stiffness using atomic force microscopy) of LO inhibitors on collagen remodelling were examined in two models, collagen hydrogels and decellularized human lung matrices. LOXL1/LOXL2 gene expression and protein levels were increased in IPF versus non-IPF. Increased collagen fibril thickness in IPF versus non-IPF lung tissues correlated with increased LOXL1/LOXL2, and decreased LOX, protein expression. β-Aminoproprionitrile (β-APN; pan-LO inhibitor) but not Compound A (LOXL2-specific inhibitor) interfered with transforming growth factor-β-induced collagen remodelling in both models. The β-APN treatment group was tested further, and β-APN was found to interfere with stiffening in the decellularized matrix model. LOXL1 activity might drive collagen remodelling in IPF lungs. The interrelationship between collagen structural remodelling and LOs is disrupted in IPF lungs. Inhibition of LO activity alleviates fibrosis by limiting fibrillar collagen cross-linking, thereby potentially impeding the formation of a pathological microenvironment in IPF.

The C-terminal binding protein (CtBP) family includes four proteins (CtBP1 [CtBP1-L], CtBP3/BARS [CtBP1-S], CtBP2, and RIBEYE) which are implicated both in transcriptional repression and in intracellular trafficking. However, the precise mechanisms by which different CtBP proteins are targeted to different subcellular regions remains unknown. Here, we report that the nuclear import of the various CtBP proteins and splice isoforms is differentially regulated. We show that CtBP2 contains a unique nuclear localization signal (NLS) located within its N-terminal region, which contributes to its nuclear accumulation. Using heterokaryon assays, we show that CtBP2 is capable of shuttling between the nucleus and cytoplasm of the cell. Moreover, CtBP2 can heterodimerize with CtBP1-L and CtBP1-S and direct them to the nucleus. This effect strongly depends on the CtBP2 NLS. PXDLS motif-containing transcription factors, such as BKLF, that bind CtBP proteins can also direct them to the nucleus. We also report the identification of a splice isoform of CtBP2, CtBP2-S, that lacks the N-terminal NLS and localizes to the cytoplasm. Finally, we show that mutation of the CtBP NADH binding site impairs the ability of the proteins to dimerize and to associate with BKLF. This reduces the nuclear accumulation of CtBP1. Our results suggest a model in which the nuclear localization of CtBP proteins is influenced by the CtBP2 NLS, by binding to PXDLS motif partner proteins, and through the effect of NADH on CtBP dimerization.Human CtBP1, the founding member of the C-terminal binding protein (CtBP) family, was originally identified as a partner of the adenovirus E1A protein (36) and derives its names from its ability to bind the sequence at the E1A Cterminal Pro-X-Asp-Leu-Ser (PXDLS). Subsequently, a second highly related factor, CtBP2, was identified in vertebrates (26,51). It now appears that CtBP1 is the first in a new family of corepressors that mediate the repression activity of a large number of transcription factors (13, 52). The corepression activity of CtBP1 and CtBP2 relies on the formation of a multiprotein complex containing the essential components for coordinated histone modifications, such as the histone deacetylases HDAC-1 and HDAC-2, the histone methyltransferase G9a, and the histone demethylase LSD1 (42, 43). Moreover, the CtBP family proteins share a high degree of homology with NAD ϩ

In our present study, a P-glycoprotein-EGFP (P-gp-EGFP) fusion plasmid was constructed and functionally expressed in HeLa cells to investigate the intracellular localization and trafficking of P-glycoprotein (P-gp). Using immunocytochemistry and fluorescent confocal microscopy techniques, colocalization studies showed that after transfection, P-gp-EGFP was progressively transported from the endoplasmic reticulum (ER) to the Golgi and finally to the plasma membrane within 12-48 hr. The degree of intracellular accumulation of daunorubicin was related to the particular localization of P-gp-EGFP. Significant daunorubicin accumulation occurred in transfected cells when P-gp-EGFP was localized predominantly within the ER, and accumulation remained high when P-gp-EGFP was mainly localized in the Golgi. However, there was little or no intracellular accumulation of daunorubicin when P-gp-EGFP was localized predominantly on the plasma membrane. Blocking the intracellular trafficking of P-gp-EGFP with brefeldin A (BFA) and monensin resulted in inhibition of traffic of P-gp-EGFP and retention of P-gp-EGFP intracellularly. Intracellular accumulation of daunorubicin also increased in the presence of BFA or monensin. Our study shows that P-gp-EGFP can be used to define the dynamics of P-gp traffic in a transient expression system, and demonstrates that localization of P-gp on the plasma membrane is associated with the highest level of resistance to daunorubicin accumulation in cells. Modulation of intracellular localization of P-gp with agents designed to selectively modify its traffic may provide a new strategy for overcoming multidrug resistance in cancer cells. © 2004 Wiley-Liss, Inc. Key words: P-glycoprotein; green fluorescent protein; multidrug resistance in cancer; P-glycoprotein intracellular localization; protein traffickingClinical drug resistance to chemotherapeutic agents is a major obstacle in the treatment of human cancers. After cancer cells become resistant to a single drug or a class of drugs, cells exhibit cross-resistance to other functionally and structurally unrelated drugs. This is known as multidrug resistance (MDR) and is a serious problem in cancer chemotherapy. 1 Various mechanisms are involved in drug resistance in cancer. Firstly, most of the resistance results from expression of ATP-dependent efflux pumps that belong to the ATP-binding cassette (ABC) transporters. Up to now, a total of 48 human ABC genes and 7 subfamilies have been identified, including P-glycoprotein (P-gp), multidrug resistance protein (MRP), breast cancer resistance protein (BCRP) and sister of P-gp (SPGP). 2 Secondly, a decrease in drug uptake can also cause resistance, the anticancer drugs failing to accumulate in cancer cells without evidence of increasing efflux. Reduced uptake occurs with drugs including methotrexate, 5-fluorouracil, 8-azaguanine and cisplatin. 3 Thirdly, resistance can also result from changes in metabolizing and detoxifying systems, such as DNA repair and the cytochrome P450 mixed-function oxidases. 4 Fin...

Extracellular matrix (ECM) remodeling contributes to the pathogenic changes in chronic obstructive pulmonary disease (COPD) and is both complex and not well understood. Collagen I, a component of the ECM altered in COPD airways, has second harmonic generation (SHG) properties. The SHG signal is coherent, propagating both forward (F) (primarily organized/mature collagen fibrils) and backward (B) (primarily disorganized/immature collagen fibrils) parallel to the incident light. The F/B SHG ratio was used to determine the proportion of organized to disorganized collagen, with lower variation in F/B ratio between sampling regions within the same patient and between patients in the same disease group compared with analyzing F and B data alone. The F/B ratio was independent of laser power drift, regions analyzed within a tissue and tissue orientation during analysis. Using this method, we identified a significant difference in collagen organization in airway tissue between COPD and non diseased. We have developed a robust optimization and calibration methodology that will allow direct comparison of data obtained at different times and from multiple microscopes, which is directly adaptable for use with other tissue types. We report a powerful new tool for advancing our understanding of pathological ECM remodeling that may uncover new therapeutic targets in the future.

No abstract